PREVALENCE AND CLINICAL PROFILE OF CARDIAC MYOSIN-BINDING PROTEIN C GENE MUTATIONS ASSOCIATED WITH HYPERTROPHIC CARDIOMYOPATHY IN TUSCANY.

-

Bibliographic Details
Main Authors:	F. Girolami, I. Passerini, A. Mariottini, J. Olivotto, F. Cecchi, D. Vargiu, F. Torricelli
Format:	Article
Language:	English
Published:	PAGEPress Publications 2003-06-01
Series:	Microbiologia Medica
Online Access:	http://www.pagepressjournals.org/index.php/mm/article/view/4231

Similar Items

The functions of cardiac myosin binding protein-C domains and their modulation by hypertrophic cardiomyopathy-causing mutations
by: Flashman, Emily Gudrun
Published: (2004)

The clinical characteristics of families with hypertrophic cardiomyopathy associated with mutations of cardiac myosin binding protein C
by: Page, S. P.
Published: (2010)

Clinical implications of #beta# cardiac myosin heavy chain mutations in hypertrophic cardiomyopathy
by: Watkins, Hugh C.
Published: (1996)

Hypertrophic cardiomyopathy in myosin-binding protein C (MYBPC3) Icelandic founder mutation carriers
by: Javier Diez, et al.
Published: (2020-06-01)

Mutation Analysis of Three Exons of Myosin-Binding Protein C3 in Patients with Hypertrophic Cardiomyopathy
by: Maryam Beigom Mobasheri, et al.
Published: (2016-11-01)

β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity
by: Arjun S. Adhikari, et al.
Published: (2019-06-01)

Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy
by: Maneiro Emilia, et al.
Published: (2010-04-01)

Classifying Cardiac Actin Mutations Associated With Hypertrophic Cardiomyopathy
by: Evan A. Despond, et al.
Published: (2018-04-01)

Genetic testing for hypertrophic cardiomyopathy: ongoing voyage from exploration to clinical exploitation
by: Iacopo Olivotto, et al.
Published: (2011-07-01)

Role of Mutations in the Essential Light Chain (ELC) of Myosin in Familial Hypertrophic Cardiomyopathy (FHC)
by: Raytman, Alexander
Published: (2011)

Mutation-Specific Phenotypes in hiPSC-Derived Cardiomyocytes Carrying Either Myosin-Binding Protein C Or α-Tropomyosin Mutation for Hypertrophic Cardiomyopathy
by: Marisa Ojala, et al.
Published: (2016-01-01)

Myosin-binding Protein C Compound Heterozygous Variant Effect on the Phenotypic Expression of Hypertrophic Cardiomyopathy
by: Julianny Freitas Rafael, et al.

Demonstrations that cardiac troponin T mutations cause hypertrophic cardiomyopathy
by: Watkins, Hugh Christian
Published: (1995)

Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition
by: Julien Robert-Paganin, et al.
Published: (2018-10-01)

Characterization of Familial Hypertrophic Cardiomyopathy on Myosin Essential Light Chain Mutation (A57G)
by: none none, et al.

The R403Q myosin mutation implicated in familial hypertrophic cardiomyopathy causes disorder at the actomyosin interface.
by: Niels Volkmann, et al.
Published: (2007-11-01)

Myogenic clones as a model in which to study myosin rod mutations that cause Familial Hypertrophic Cardiomyopathy
by: Colman, Lucy Mary
Published: (2009)

Beta-Myosin Heavy Chain (β-MHC) and Myosin Binding Protein C (MyBP-C) genes mutation in Bangladeshi hypertrophic Cardiomyopathy Patients: a genotype-phenotype correlation
by: Laila Anjuman Banu, et al.
Published: (2017-12-01)

Quantitation of myosin heavy chain isoforms for assessment of the severity of hypertrophic cardiomyopathy
Published: ()

Prolonged cross-bridge binding triggers muscle dysfunction in a Drosophila model of myosin-based hypertrophic cardiomyopathy
by: William A Kronert, et al.
Published: (2018-08-01)

A Novel Myosin Essential Light Chain Mutation Causes Hypertrophic Cardiomyopathy with Late Onset and Low Expressivity
by: Paal Skytt Andersen, et al.
Published: (2012-01-01)

Effects of cardiomyopathy-related mutations in alpha-cardiac actin on the actin-myosin complex
by: Dahari
Published: (2012)

Sudden cardiac death in hypertrophic cardiomyopathy
by: O'Mahony, C.
Published: (2013)

Cardiac aldosterone in subjects with hypertrophic cardiomyopathy
by: Wenxia Chai, et al.
Published: (2006-12-01)

Cardiac Sarcoidosis Mimicking Hypertrophic Cardiomyopathy
by: Daniel R. Feldman, MD, et al.
Published: (2020-11-01)

Cardiac Myxoma in a Patient With Hypertrophic Cardiomyopathy
by: Weng-Tein Gi, MD, MSc, et al.
Published: (2020-03-01)

Mutation-Specific Calcium Dysregulation in Hypertrophic Cardiomyopathy
by: Lehman, Sarah, et al.
Published: (2018)

Functional characterisation of point mutations in cardiac troponin I that cause familial hypertrophic cardiomyopathy
by: Elliott, Kathryn
Published: (2001)

Novel FHL1 Mutation Associated With Hypertrophic Cardiomyopathy, Sudden Cardiac Death, and Myopathy
by: M. Scott Binder, MD, et al.
Published: (2020-03-01)

Hypertrophic Cardiomyopathy Cardiac Troponin C Mutations Differentially Affect Slow Skeletal and Cardiac Muscle Regulation
by: Jose R. Pinto, et al.
Published: (2017-04-01)

Effects of myosin variants on interacting-heads motif explain distinct hypertrophic and dilated cardiomyopathy phenotypes
by: Lorenzo Alamo, et al.
Published: (2017-06-01)

Hypertrophic Cardiomyopathy in Adolescence
by: Paul F. Kantor, MBBCh, MSc, et al.
Published: (2021-01-01)

Emerging Medical Treatment for Hypertrophic Cardiomyopathy
by: Alessia Argirò, et al.
Published: (2021-03-01)

Cardiac Thin Filament Regulatory Proteins Familial Hypertrophic Cardiomyopathy Mutations and Post Translational Modifications

Effect of hypertrophic and dilated cardiomyopathies associated mutations in troponin I on cardiac thin filament dynamics
by: Al-Sarayreh, Sameeh Abdulkareem
Published: (2011)

Childhood Hypertrophic Cardiomyopathy: A Disease of the Cardiac Sarcomere
by: Gabrielle Norrish, et al.
Published: (2021-07-01)

Defying the Odds of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
by: Ara H. Rostomian, MD, MPH, MBA, et al.
Published: (2020-06-01)

Diastolic function and prognosis in hypertrophic cardiomyopathy
by: Alvares, R. F.
Published: (1980)

Transcriptional regulation of cardiac genes balance pro- and anti-hypertrophic mechanisms in hypertrophic cardiomyopathy
by: Nina Gennebäck, et al.
Published: (2012-06-01)

Generation of an induced pluripotent stem cell line from a hypertrophic cardiomyopathy patient with a pathogenic myosin binding protein C (MYBPC3) p.Arg502Trp mutation
by: Mira Holliday, et al.
Published: (2018-12-01)

Cannot write session to /tmp/vufind_sessions/sess_g0ceof2et263nh0svv5gsr7m5i